|
GLSI Greenwich Lifesciences Inc 1799788 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-5,657,137.00 |
| Balance Sheet |
|
Current Assets
|
$10,505,435.00 |
|
Assets
|
$10,505,435.00 |
|
Current Liabilities
|
$5,235,229.00 |
|
Liabilities
|
$5,235,229.00 |
|
Equity
|
$5,270,206.00 |
|
Shares Out
|
14665993.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-4,702,498.00 |
| Market Analysis |
Market Cap
|
$205,617,221.86 |
|
Price
|
$13.90 |
|
BVPS
|
0.36 |
|
PB
|
38.94 |
|
EPS
|
-0.39 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:31 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:28 |
|
| Jul |
Aug |
Sep |
| 2026-06-01 |
-1.43 |
|
|
|
|
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-14 |
-0.30 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view GLSI documents filed with the SEC.
GLSI Filings
Clear
